Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
QuantoBio
company
About
QuantoBio is the developer of high-quality reagents for immunology research.
- 101 - 250
Details
- Last Funding Type
- Funding Round
- Last Funding Money Raised
- ¥15M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Aug 1, 2009
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥64.50M
QuantoBio has raised a total of
¥64.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 19, 2017 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 19, 2017 | Post-IPO Equity | ¥45M | 1 | — | — | Detail |
| Feb 8, 2014 | Funding Round | ¥15M | 1 |
|
— | Detail |
| Aug 19, 2013 | Angel | ¥4.50M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
QuantoBio is funded by 3 investors.
Shanghai Chenshan Investment Management
and Beijing Kanghua Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Funding Round |
|
|
Yes | Angel |
|
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
